Cisplatin (CDDP): Mechanistic Benchmarks for Cancer Research

2026-01-19

Cisplatin (CDDP) is a gold-standard DNA crosslinking agent and chemotherapeutic compound for cancer research. This article details its molecular mechanism, experimental evidence, and best practices for apoptosis assays and tumor growth inhibition in xenograft models. APExBIO’s Cisplatin (SKU A8321) is referenced as a benchmark product for research applications.